Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The National Pharmaceutical Pricing Authority (NPPA) has notified a 0.64956% increase in the Wholesale Price Index (WPI) for 2025 over 2024. Importers and manufacturers of Scheduled drugs and medical device are now permitted to increase the prices on the basis of WPI without prior approval from the government from April 1, 2026.
Source: shortlink.uk/1mYsg

2. The Central Drugs Standard Control Organization (CDSCO) has clarified that all IVF-related devices, including sperm washing kits and intrauterine insemination tools, are regulated as medical devices under the Drugs and Cosmetics Act. Import, manufacture, and sale of these devices require proper licensing to ensure compliance and prevent unauthorized trade.
Source: shortlink.uk/1mYsj

3. India’s Central Drug authority, (CDSCO) has streamlined the procedure for review and processing Written Confirmation certificate (WCC) applications submitted through the SUGAM portal for export of Active Pharmaceutical Ingredients (API) to EU for human use. The move aims to improve efficiency aligning with EU GMP compliance requirements under Article 46(2)(b) of Directive 2001/83/EC.
Source: shortlink.uk/1sbyd

4. The National Medical Commission (NMC), following a Supreme Court of India ruling, now limits stem cell therapy to approved conditions only, so far there are 32 approved conditions. Unproven uses outside clinical trials are banned, with strict ethical rules and legal action to prevent misuse and protect patients.
Source: shortlink.uk/1mYsV

5. The Central Consumer Protection Authority (CCPA) has directed hotels and restaurants to stop adding charges such as “LPG charges” and “fuel cost recovery” to customer bills, terming the practice an unfair trade practice, and warning of strict action. The CCPA clarified LPG and electricity, are part of running a business and should be factored into final menu prices.
Source: shortlink.uk/1mYt2

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Jammu and Kashmir and Ladakh High Court ruled that prosecution under the Drugs and Cosmetics Act cannot proceed if the accused is deprived of the statutory right to seek re-analysis of a drug sample by the Central Drugs Laboratory. The court quashed proceedings where the expiry of the sample’s shelf life prevented the accused from exercising this legal safeguard of having the samples tested by the Central Drugs Laboratory.
Source: shortlink.uk/1mQEt

2. India’s central food regulator (FSSAI) has amended the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011. Key changes allow the authority to set turnover thresholds for registration, grant instant registration on document submission, recognize street vendors registered under the Street Vendors law, introduce risk-based inspections and audits, and suspend licences for non-payment of fees or failure to file returns.
Source: shortlink.uk/1mQEx

3. The Central Drugs Standard Control Organisation (CDSCO) has delegated key regulatory functions related to veterinary drugs to its zonal offices. Zonal offices will now process Test License (Form 11) applications for import and issue NOCs for Form 29 licenses for manufacturing veterinary drugs for testing or analysis, excluding biologicals.
Source: shortlink.uk/1s3ug

4. India’s Drugs Technical Advisory Board, in its 93rd meeting, recommended amending the Drugs Rules, 1945 to introduce licensing provisions for drug marketers. The move aims to strengthen regulatory oversight and monitoring of entities that market drugs manufactured by other companies under their own label.
Source: shortlink.uk/1s3uq

5. The Food Safety and Standards Authority of India has reportedly encouraged plant-based food manufacturers to include QR codes on product labels to help consumers easily access ingredient lists and nutritional information. The regulator said the move currently voluntary can address label space limitations, improve transparency, and build consumer trust in the rapidly growing plant-based food sector.
Source: shortlink.uk/1s3uD

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Central Pollution Control Board (CPCB) has extended the deadline for registered Producers, Importers and Brand Owners (PIBOs) to file Annual Returns for FY 2024–25 under the Plastic Waste Management Rules, 2016 until March 31, 2026. Non-compliance may attract environmental compensation.
Source: shortlink.uk/1rAfG

2. The Central Pollution Control Board has issued show cause notices to PIBOs for failing to meet EPR obligations and not submitting Annual Returns for FY 2022–23 under the Plastic Waste Management Rules, 2016. Defaulters will face environmental compensation and tighter enforcement from authorities
Source: shortlink.uk/1rAg8
Source: shortlink.uk/1rAga

3. The Central Pollution Control Board (CPCB) has issued show cause notices to producers, importers, and brand owners (PIBOs) for failing to meet Extended Producer Responsibility obligations, fulfil targets, and file annual returns under the Plastic Waste Management Rules, 2016 for FY 2022–23. Non-compliant entities may have to pay environmental compensation, face penalties, and higher future targets. Entities must respond latest by 26.03.2026or face further regulatory and legal action.
Source: shortlink.uk/1mol6

4. The Karnataka government has released a draft policy promoting responsible digital use among students, focusing on curbing screen addiction, cyber risks, and mental health impacts. The move aligns with its broader push to restrict social media access for minors and regulate device usage.
Source: shortlink.uk/1mol8

5. Parliamentary panel has reportedly urged the Department of Pharmaceuticals to address administrative delays affecting the Promotion of Research and Innovation in Pharma MedTech Sector scheme after significant underutilisation of funds. Despite increased allocations, spending remained low. Revised guidelines and stronger monitoring are expected to improve execution and outcomes.
Source: shortlink.uk/1rAgj